SCHEMBL7539726

SCHEMBL7539726

CCCCCNc1nncs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
CYP1A2 P05177 1/20 0.57
AKT1 P31749 8/20 0.46
PDPK1 O15530 1/20 0.46
ABCB11 O95342 1/20 0.46
AKT2 P31751 1/20 0.46
GAB1 Q13480 1/20 0.46
AKT3 Q9Y243 1/20 0.46
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
STAT1 P42224 1/20 0.45
RAB9A P51151 1/20 0.45
MMP3 P08254 1/20 0.42
PKM P14618 1/20 0.41
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12571300 0.94 TSHR (0.59) TSHRCYP1A2AKT1PDPK1ABCB11
SCHEMBL11315263 0.79 CYP1A2 (0.59) TSHRCYP1A2AKT1ALDH1A1MAPT
SCHEMBL94500 0.78
SCHEMBL5096038 0.73 CYP1A2 (1.00) TSHRCYP1A2AKT1ALDH1A1MAPT
SCHEMBL11321928 0.73 TSHR (0.46) TSHRCYP1A2MAPTCA1CA2
SCHEMBL11321178 0.71 CYP1A2 (0.49) TSHRCYP1A2AKT1ALDH1A1MAPT
SCHEMBL28887731 0.71 PKM (0.45) TSHRCYP1A2AKT1PDPK1ABCB11
SCHEMBL28887723 0.71 AKT1 (0.44) TSHRCYP1A2AKT1PDPK1ABCB11
SCHEMBL28887718 0.71 PKM (0.42) TSHRCYP1A2AKT1PDPK1ABCB11
SCHEMBL6275094 0.70 TSHR (0.57) TSHRCYP1A2ALDH1A1MAPTCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP disclosed
EP-1064273-A2 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 2001-01-03 EP disclosed
US-6150385-A VIRICIDE WITH ACTIVITY AGAINST CYTOMEGALO VIRUS (CMV), HERPES VIRUS INCLUDING VARICELLA ZOSTER VIRUS, THE EPSTEIN-BARR VIRUS, THE HERPES SIMPLEX VIRUS, AND THE HUMAN HERPES VIRUS TYPE 8 (HHV-8) PHARMACIA & UPJOHN COMPANY (US) 2000-11-21 US disclosed
WO-1999047507-A2 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1999-09-23 WO disclosed
US-4229577-A IMPROVED REACTIVITY, MINIMAL FOG, HIGH FASTNESS TO LIGHT CIBA-GEIGY AG (CH) 1980-10-21 US disclosed
US-4115121-A TWO-EQUIVALENT BENZOYLACETANILIDE METHYLENE COUPLERS CIBA-GEIGY AG (CH) 1978-09-19 US disclosed
US-3728354-A 2-PERCHLOROCROTONYLAMINO-5-TRIFLUOROMETHYL-1,3,4-THIADIAZOLE BAYER AG 1973-04-17 US disclosed